Motif Bio PLC | Mutual Funds
Mutual Funds that own Motif Bio PLC
Perpetual Income & Growth Investment Trust Plc
26,633,996
8.98%
0
0.78%
03/31/2018
Invesco Perpetual UK Equity Pension Fund
10,262,542
3.46%
0
1.08%
03/29/2018
Keystone Investment Trust Plc
6,752,722
2.27%
0
0.62%
04/30/2018
2,375,381
0.8%
1,408,865
1.72%
06/29/2018
Aviva Investors - European Equity Fund
1,698,925
0.56%
0
0.34%
06/30/2018
1,260,885
0.43%
-37,406
3%
06/29/2018
Deutsche Postbank Europafonds Plus
600,000
0.2%
0
0.8%
06/29/2018
3ik - Strategiefonds III
363,000
0.12%
0
0.98%
09/30/2017
3ik - Strategiefonds II
296,500
0.1%
0
0.64%
09/30/2017
3ik - Strategiefonds I
296,500
0.1%
296,500
0.65%
02/28/2018
| Address |
5 Independence Way
Princeton New Jersey 08540
United States
|
|
Employees
|
- |
| Website |
https://www.motifbio.com/ |
| Updated |
07/08/2019 |
| Motif Bio Plc is a clinical stage biopharmaceutical company which develops novel antibiotics designed to be effective against serious and life-threatening infections caused by multi-drug resistant bacteria. It pipeline of antibiotics includes iclaprim, and MTF-001, a preclinical program to design a dihydrofolate reductase inhibitor (DHFRi). The company was founded on November 20, 2014 and is headquartered in New York, NY. |
